BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 10889450)

  • 1. DHODH: a promising target in the treatment of T-cell acute lymphoblastic leukemia.
    Sexauer AN; Alexe G; Gustafsson K; Zanetakos E; Milosevic J; Ayres M; Gandhi V; Pikman Y; Stegmaier K; Sykes DB
    Blood Adv; 2023 Nov; 7(21):6685-6701. PubMed ID: 37648673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression.
    Hai Y; Fan R; Zhao T; Lin R; Zhuang J; Deng A; Meng S; Hou Z; Wei G
    Pharmacol Res; 2024 Apr; 202():107115. PubMed ID: 38423231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mysteries of partial dihydroorotate dehydrogenase inhibition and leukemia terminal differentiation.
    Saunthararajah Y
    Haematologica; 2020 Sep; 105(9):2191-2193. PubMed ID: 33054042
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain pyrimidine nucleotide synthesis and Alzheimer disease.
    Pesini A; Iglesias E; Bayona-Bafaluy MP; Garrido-Pérez N; Meade P; Gaudó P; Jiménez-Salvador I; Andrés-Benito P; Montoya J; Ferrer I; Pesini P; Ruiz-Pesini E
    Aging (Albany NY); 2019 Sep; 11(19):8433-8462. PubMed ID: 31560653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia.
    Stuani L; Sabatier M; Sarry JE
    BMC Biol; 2019 Jul; 17(1):57. PubMed ID: 31319822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrosative stress-mediated inhibition of
    Rolly NK; Lee SU; Imran QM; Hussain A; Mun BG; Kim KM; Yun BW
    3 Biotech; 2019 Jul; 9(7):273. PubMed ID: 31245237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Powerhouse to Perpetrator-Mitochondria in Health and Disease.
    Fakouri NB; Hansen TL; Desler C; Anugula S; Rasmussen LJ
    Biology (Basel); 2019 May; 8(2):. PubMed ID: 31083572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetylcysteine and vitamin E rescue animal longevity and cellular oxidative stress in pre-clinical models of mitochondrial complex I disease.
    Polyak E; Ostrovsky J; Peng M; Dingley SD; Tsukikawa M; Kwon YJ; McCormack SE; Bennett M; Xiao R; Seiler C; Zhang Z; Falk MJ
    Mol Genet Metab; 2018 Apr; 123(4):449-462. PubMed ID: 29526616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Mitochondrial Dysfunction in the Progression of Alzheimer's Disease.
    Desler C; Lillenes MS; Tønjum T; Rasmussen LJ
    Curr Med Chem; 2018; 25(40):5578-5587. PubMed ID: 28618998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia.
    Ashton TM; Fokas E; Kunz-Schughart LA; Folkes LK; Anbalagan S; Huether M; Kelly CJ; Pirovano G; Buffa FM; Hammond EM; Stratford M; Muschel RJ; Higgins GS; McKenna WG
    Nat Commun; 2016 Jul; 7():12308. PubMed ID: 27453292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting mTORC1-mediated metabolic addiction overcomes fludarabine resistance in malignant B cells.
    Sharma A; Janocha AJ; Hill BT; Smith MR; Erzurum SC; Almasan A
    Mol Cancer Res; 2014 Sep; 12(9):1205-15. PubMed ID: 25061101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial uncoupling and the reprograming of intermediary metabolism in leukemia cells.
    Vélez J; Hail N; Konopleva M; Zeng Z; Kojima K; Samudio I; Andreeff M
    Front Oncol; 2013; 3():67. PubMed ID: 23565503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of mitochondrial dysfunction on cytosolic nucleotide metabolism.
    Desler C; Lykke A; Rasmussen LJ
    J Nucleic Acids; 2010 Aug; 2010():. PubMed ID: 20862377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity.
    Klivenyi P; Gardian G; Calingasan NY; Yang L; von Borstel R; Saydoff J; Browne SE; Beal MF
    Neuromolecular Med; 2004; 6(2-3):87-92. PubMed ID: 15970626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect inhibition of mitochondrial dihydroorotate dehydrogenase activity by nitric oxide.
    Beuneu C; Auger R; Löffler M; Guissani A; Lemaire G; Lepoivre M
    Free Radic Biol Med; 2000 Apr; 28(8):1206-13. PubMed ID: 10889450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide inhibits the cytochrome oxidase but not the alternative oxidase of plant mitochondria.
    Millar AH; Day DA
    FEBS Lett; 1996 Dec; 398(2-3):155-8. PubMed ID: 8977097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased activity and sensitivity of mitochondrial respiratory enzymes to tumor necrosis factor alpha-mediated inhibition is associated with increased cytotoxicity in drug-resistant leukemic cell lines.
    Jia L; Kelsey SM; Grahn MF; Jiang XR; Newland AC
    Blood; 1996 Mar; 87(6):2401-10. PubMed ID: 8630404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple inhibitor analysis of the brequinar and leflunomide binding sites on human dihydroorotate dehydrogenase.
    McLean JE; Neidhardt EA; Grossman TH; Hedstrom L
    Biochemistry; 2001 Feb; 40(7):2194-200. PubMed ID: 11329288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroorotate dehydrogenase in oxidative phosphorylation and cancer.
    Boukalova S; Hubackova S; Milosevic M; Ezrova Z; Neuzil J; Rohlena J
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165759. PubMed ID: 32151633
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.